GSK (LON:GSK – Get Free Report) had its target price dropped by equities researchers at JPMorgan Chase & Co. from GBX 1,400 ($17.97) to GBX 1,300 ($16.69) in a report released on Tuesday, FlyOnTheWall reports. JPMorgan Chase & Co.‘s target price points to a potential downside of 5.26% from the stock’s previous close. A number […]